Thursday, October 8, 2026 SourcesAbout🌓
🇨🇦 CA ▾
Américas🇧🇷 Brasil🇺🇸 United States🇨🇦 Canada🇻🇪 Venezuela🇲🇽 México🇦🇷 Argentina
Europa🇫🇷 France🇬🇧 United Kingdom🇪🇸 España🇵🇹 Portugal🇩🇪 Deutschland🇷🇺 Россия
Ásia-Pacífico🇯🇵 日本🇦🇺 Australia🇮🇳 India🇰🇷 대한민국🇨🇳 中国
África🇿🇦 South Africa
BREAKING
› Opinion: Ultra-rich British Columbians like me should welcome new taxes› Opinion: Housing and climate are inextricably linked. We must see action on both this election› B.C. Conservatives drop, distance themselves from Victoria-Beacon Hill candidate after controversial tweets surface› LILLEY: Out of ideas and out of gas, Chow’s campaign runs on fear› Senators’ Hoyt Stanley to make NHL debut vs. Flyers› Surrey debt collector fined $34,000 for harassment of customers, threat of 'financial annihilation'› The suspicious texts on day of Toronto airport gold heist between Air Canada workers accused of pulling it off› Braid: Separatist leaders' bumbling in U.S. at least warned us of American threat› Canucks on Sportsnet: Vancouver vs. Carolina› BATRA’S BURNING QUESTIONS: Will Toronto choose Olivia Chow or Brad Bradford to lead the city?› Opinion: Ultra-rich British Columbians like me should welcome new taxes› Opinion: Housing and climate are inextricably linked. We must see action on both this election› B.C. Conservatives drop, distance themselves from Victoria-Beacon Hill candidate after controversial tweets surface› LILLEY: Out of ideas and out of gas, Chow’s campaign runs on fear› Senators’ Hoyt Stanley to make NHL debut vs. Flyers› Surrey debt collector fined $34,000 for harassment of customers, threat of 'financial annihilation'› The suspicious texts on day of Toronto airport gold heist between Air Canada workers accused of pulling it off› Braid: Separatist leaders' bumbling in U.S. at least warned us of American threat› Canucks on Sportsnet: Vancouver vs. Carolina› BATRA’S BURNING QUESTIONS: Will Toronto choose Olivia Chow or Brad Bradford to lead the city?
Business

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Financial Post ·

PARSIPPANY, N.J., Sept.

18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from a discrete choice experiment highlighting preferred healthcare provider (HCP) treatment attributes when selecting a VMAT2 inhibitor for the treatment of TD in older patients (aged ≥55 years).

The new findings were presented at Psych Congress, held September 15 – 19, 2026, in New Orleans, LA.

Read More

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

Lithium Argentina to Release Third Quarter 2026 Results on November 10, 2026

Financial Post · 50 min ago

September 2026 Quarter Production Update

Financial Post · 56 min ago

Parex Resources Announces Production Update and Timing of Q3 2026 Results

Financial Post · 1 h ago

Aritzia raises 2027 outlook as Q2 revenue up 44 per cent to $1.17 billion

Financial Post · 1 h ago

More in Business

See all ›

Lithium Argentina to Release Third Quarter 2026 Results on November 10, 2026

Financial Post · 50 min ago

September 2026 Quarter Production Update

Financial Post · 56 min ago

Parex Resources Announces Production Update and Timing of Q3 2026 Results

Financial Post · 1 h ago

Aritzia raises 2027 outlook as Q2 revenue up 44 per cent to $1.17 billion

Financial Post · 1 h ago

News of the day: Trade deal in limbo, ‘excessive’ tax breaks, AI threats, giving up homeownership, business debt and more

Financial Post · 1 h ago

Bombardier Expands Top-Industry Ranked Support Network with New Line Maintenance Station in Sydney, Australia, Further Enhancing Care and Convenience for Customers in Asia-Pacific

Financial Post · 2 h ago